September 20, 2007
CTSA comes to Michigan
I'm very excited that UM has been chosen for a Clinical and Translational Science Award. According to the UM press release, it's the largest NIH grant ever to the UM Medical School. This also is the university's opportunity to make a major contribution to transforming clinical research and accelerating the translation of research results into health care applications. More specifically for the library, it's an opportunity for us to rethink our role in UM's research operation and explore with our health sciences schools and health system the implications and applications of the changing information environment.
September 19, 2007
Times to Stop Charging for Parts of Its Web Site
Does anyone other than me think this is a sign of the times (as it were) and another stake in the heart of paid-subscription models for online access? I wouldn't want to overgeneralize from a newspaper to a scientific journal, but I think the underlying theme is "the people have spoken."
September 12, 2007
As my colleague, Anna Ercoli Schnitzner, blogged on our HSL staff blog and as was widely reported in the NY Times and elsewhere, Elsevier is piloting advertising-funded open access to a subset of Science Direct, the oncology journals. I find it ironic that I learned of this the same day as the AAP announced its PRISM initiative.
I'm not going to respond at length to PRISM - Peter Suber has already done that more than adequately, and it's generated a great deal of comment in the biblioblogosphere. I'm just amazed that AAP is essentially choosing to follow the RIAA and MPAA approach which could be described as "the beatings (aka subpoenas) will continue until morale improves." Does anyone remember the definition of insanity?
As for Elsevier, I cynically assume that this is a self-interested move on their part, but so what? It's an experiment worth trying. Whether it works, and if it does how it will impact medical libraries or libraries in general remains to be seen. But I'm optimistic that it's not the "killer app" that's going to put us out of business.